Independent Candidate Serum Protein Biomarkers of Response to Adalimumab and to Infliximab in Rheumatoid Arthritis: An Exploratory Study

Response to treatment of rheumatoid arthritis shows large inter-individual variability. This heterogeneity is observed with all the anti-rheumatic drugs, including the commonly used TNF inhibitors. It seems that drug-specific and target-specific factors lead individual patients to respond or not to...

Descripción completa

Detalles Bibliográficos
Autores principales: Ortea, Ignacio, Roschitzki, Bernd, López-Rodríguez, Rosario, Tomero, Eva G., Ovalles, Juan G., López-Longo, Javier, de la Torre, Inmaculada, González-Alvaro, Isidoro, Gómez-Reino, Juan J., González, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822871/
https://www.ncbi.nlm.nih.gov/pubmed/27050469
http://dx.doi.org/10.1371/journal.pone.0153140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822871/
https://www.ncbi.nlm.nih.gov/pubmed/27050469
http://dx.doi.org/10.1371/journal.pone.0153140

Ejemplares similares